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Research article 
Ερευνητικό άρθρο 
Sarcoptic mange in guanacos: transmission to sheep and goats and 
treatment with moxidectin 
Papadopoulos E.1, Fthenakis G.C.2 
faculty of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece 
2
 Veterinary Faculty, University of Thessaly, 43100 Kardits a, Greece 
Σαρκοπτική ψώρα σε γκουανάκο: μετάδοση σε πρόβατα και αίγες και 
θεραπευτική αγωγή με μοξιδεκτίνη 
Παπαδόπουλος Η.
1
, Φθενάκης Γ.Χ.
2 
Κτηνιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, 54124 Θεσσαλονίκη 
2
Τμήμα Κτηνιατρικής, Πανεπιστήμιο Θεσσαλίας, 43100 Καρδίτσα 
ABSTRACT. Two guanacos were diagnosed with sarcoptic mange, confirmed by recovery of mites, using standard para-
sitological techniques, from skin scrapings. Each animal was treated twice, 10 days apart, with moxidectin 1% inj. sol. 
administered subcutaneously. Dose rate was 0.2 mg/kg bodyweight. After the injections, safety observations were made 
for local or general adverse reactions. Moreover, clinical examinations were made and skin scrapings were collected and 
examined. After treatment, neither changes were seen at the site of injection, nor general reactions were recorded. The mange 
skin lesions had disappeared by 42nd day post-treatment. No mites were recovered 21 d post-treatment. Thereafter, sheep 
and goats neighbouring the guanacos developed sarcoptic mange, confirmed by clinical findings and recovery of mites. In 
contrast, horses, donkeys and dogs, also neighbouring the guanacos, did not develop sarcoptic mange. It is concluded that 
moxidectin can be used for the treatment of sarcoptic mange in guanacos. The findings support a hypothesis that mites may 
be transmitted easily among ruminants; these are in line with results of in vitro studies, indicating that mite strains from 
ruminants belong to the same cluster. 
Keywords: goat, guanaco, moxidectin, sarcoptic mange, sheep, transmission, treatment 
ΠΕΡΙΑΗΨΗ. Έγινε διάγνωση σαρκοπτικής ψώρας σε δύο γκουανάκο {Lama guanicoe), αρχικά με βάση τα κλινικά ευρή­
ματα, η οποία επιβεβαιώθηκε με την ανεύρεση ακάρεων Sarcoptes scabiei σε ξέσματα δέρματος από τα προσβεβλημένα 
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ζώα. Θεραπευτικά, χορηγήθηκε μοξιδεκτίνη 1% ενέσιμο διάλυμα, σε δόση 0,2 mg ανά kg σωματικού βάρους, δύο φορές σε 
μεσοδιάστημα 10 ημερών. Μετά τη χορήγηση, δεν παρατηρήθηκαν συστηματικής φύσεως αντιδράσεις, ούτε αντιδράσεις 
στο σημείο της ένεσης. Οι δερματικές αλλοιώσεις της ψώρας δεν ήταν εμφανείς κατά την κλινική εξέταση των ζώων την 
42η ημέρα μετά τη θεραπευτική αγωγή. Στη συνέχεια, πρόβατα και αίγες, που γειτνίαζαν με τα γκουανάκο, εκδήλωσαν σαρ-
κοπτική ψώρα, η διάγνωση της οποίας βασίστηκε στα κλινικά και τα παρασιτολογικά ευρήματα. Αντίθετα, άλογα, όνοι και 
σκύλοι, που επίσης γειτνίαζαν με τα γκουανάκο, δεν εκδήλωσαν σαρκοπτική ψώρα. Συμπεραίνεται ότι η μοξιδεκτίνη μπορεί 
να χρησιμοποιηθεί στη θεραπευτική αγωγή της σαρκοπτικής ψώρας σε γκουανάκο. Επιπλέον, τα ευρήματα υποστηρίζουν 
την υπόθεση ότι τα ακάρεα S. scabiei μπορούν να μεταδοθούν εύκολα μεταξύ μηρυκαστικών ζώων και είναι συμβατά με 
αποτελέσματα in vitro μελετών, τα οποία υποδεικνύουν ότι τα στελέχη του ακάρεος που προκαλούν ψώρα σε μηρυκαστικά, 
ανήκουν στην ίδια ομάδα. 
Λέξεις ευρετηρίασης: αίγες, γκουανάκο, θεραπευτική αγωγή, μετάδοση, μοξιδεκτίνη, πρόβατα, σαρκοπτική ψώρα 
INTRODUCTION 
Injectable macrocyclic lactones are considered to be effective for the treatment of sarcoptic mange. 
However, drugs ofthat family are licenced for use only 
in some animal species: cattle, sheep and pigs. Never­
theless, the disease also affects other animal species, 
for which no registered ectoparasiticides are available. 
Therefore, clinicians rely on published evidence (clini­
cal trials, case reports) for valid information in order to 
control the disease in such animal species. 
Numbers of guanacos (Lama guanicoe), along 
with those of llamas, alpacas and vicunas, are cur­
rently increasing in Europe and North America. These 
animals are used for fibre production, as pets or for 
breeding. Although their commercial value is increas­
ing, leading to requirements for increased standards 
of veterinary care (Anderson and Whitehead, 2009), 
there is limited information in the scientific literature 
regarding treatment of specific diseases, including 
sarcoptic mange, of these animals (Ballweber, 2009; 
Lusat et al., 2009). 
In this paper, we detail the therapeutic approach 
to sarcoptic mange in two guanacos and we present 
evidence of transmission of the causative agent to 
neighbouring sheep and goats. 
MATERIALS AND METHODS 
Description of the farm and clinical findings in the 
guanacos 
The case described occurred in a hobby animal 
farm located in the outskirts of Thessaloniki, North­
ern Greece. The farm contained 12 sheep, 6 goats, 4 
dogs, 4 pony horses, 2 donkeys and 2 guanacos, all 
maintained as pets. Although no direct mixing of the 
various animal species was practiced, the paddocks 
where the guanacos were maintained, adjoined those of 
the sheep and goats, of the horses and donkeys and of 
the dogs. Paddocks were separated by wooden fences. 
The guanacos (one male, one female) were the most 
recent introductions into the farm, where no history of 
sarcoptic mange had ever been reported. 
Within one month after their import from Germany, 
both guanacos showed crusty and hyperkeratotic skin 
lesions located in the neck and shoulders, the outer 
surface of the thighs and the thoracic region surfaces, 
coupled with intense pruritus. A tentative diagnosis of 
sarcoptic mange was considered. 
Parasitological examinations of samples from the 
guanacos 
Skin scrapings were collected from the part of the 
lesions bordering healthy issue; scrapings from four 
sites were collected from each animal and, approxi­
mately, 1 to 2 cm2 of each site were scraped. A scal­
pel blade was dipped into glycerine, a skin fold was 
pinched between the forefinger and the thumb and 
whilst holding the blade at right angle to the skin, 
scrape was carried out until blood seeped from the 
abrasion. Scrapings from each animal were transferred 
into a Petri dish containing some damp cotton wool. 
Samples were examined within 2 h of collection. 
Each sample was moistened with approximately 
5 ml 5% KOH and heated until hair and epidermal 
scales were dissolved and cooled down. The mixture 
was transferred to a tube and was centrifuged at 10 g 
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for 10 min. The sediment was transferred to slides, for 
microscopic examination. Only presence or absence 
of mites was recorded; no counts were made. Iden­
tification of mites was made by using the criteria of 
Bowman (2008). 
Further skin scrapings were collected from each 
animal, 21 d (D32) and 42 d (D53) after the second 
moxidectin injection, as detailed herebelow. 
Treatment of the guanacos 
Each guanaco was treated twice, 10 days apart 
(on DO and on Di l ) , with moxidectin 1% inj. sol. 
(CYDECTIN; Pfizer, New York, USA), administered 
subcutaneously at the right side of the neck. Dose rate 
was 0.2 mg/kg body weight. 
Subsequently to treatment (at 3 hours, 8 hours and 
24 hours post-treatment; DO and Dl), the site of injec­
tion was palpated in both animals and compared to 
that of the contralateral side, in order to assess possible 
changes (e.g. swellings). At each of the above time-
points, both animals were also observed to record any 
general adverse reactions; observations were carried 
out for 15 min to permit a reliable assessment. 
Clinical findings, parasitological examinations and 
treatment of other animals in the farm 
On D32, mild skin lesions characteristic of sar-
coptic mange were observed in 4 sheep and 2 goats. 
Lesions were scored T o r '2' on the '0'-'4' scale 
described by Papadopoulos and Fthenakis (1999). 
At that time and contrary to veterinary advice, the 
farmer did not accept sampling for parasitological 
examination, neither did he perform any treatment to 
the animals. 
On D53, skin lesions were observed in all (12) 
sheep and in 4 of the 6 goats. Lesions were scored ' 1 ' 
to '4' for sheep and ' Γ to ' 3 ' for goats on the above 
scale. At that time, skin scrapings were collected 
from four sheep and three (2 affected and 1 clini­
cally healthy) goats for parasitological examination, 
as detailed above. 
At that time, all other animals neighbouring to the 
guanacos (pony horses, donkeys, dogs) in the farm 
were also clinically examined for skin lesions and no 
abnormalities were found. Moreover, a skin scraping 
was collected from each of these animals. 
All sheep and goats were treated twice, 10 days 
apart (on D56 and on D67), with moxidectin 1% inj. 
sol., administered subcutaneously. Dose rate was 0.2 
mg/kg bodyweight. Horses, donkeys and dogs were 
left untreated. 
Further clinical examinations were performed in 
the sheep and goats 21 d (D88), 42 d (D109) and 77 d 
(D144) after the second moxidectin injection. On D88 
and D109, skin scrapings were collected from the four 
sheep and three goats, same as above. Finally and also 
on each of these occasions, all other animals in the farm 
were clinically examined and sampled (skin scrapings). 
RESULTS 
Before treatment, mites were recovered from all 
four samples collected from each guanaco. All mites 
were identified as Sarcoptes scabiei, confirming the 
clinical diagnosis of sarcoptic mange. 
After treatment, no changes were seen at the site 
of injection of any of the two guanacos. Moreover, no 
general reactions were recorded. Skin lesions (crusts, 
hyperkeratosis) were milder on D32 and had disap­
peared on D53. No mites were recovered from the two 
animals in any of the two post-treatment samplings 
(D32, D53). Sarcoptes scabiei was also recovered from 
skin scrapings of all clinically affected sheep and goats, 
but not from those of the clinically healthy goat. Skin 
lesions were milder on D109 and had disappeared on 
D144. 
In no occasion, were any of the other animals 
(pony horses, donkeys, dogs) found to have clinical 
signs characteristic of sarcoptic mange. Moreover, in 
no case mites were recovered from scrapings collected 
from these animals. 
DISCUSSION 
Treatment of sarcoptic mange in guanacos 
Sarcoptic mange is reported to be the most impor­
tant disease in South American camelids, accounting 
for 95% of production losses by these animals (Ballwe-
ber, 2009). The disease is caused by Sarcoptes scabiei 
var. aucheniae (Bravo and Fowler, 2001; Ballweber, 
2009). 
To the best of our knowledge, no reports are avail­
able in the literature regarding treatment of sarcop-
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tic mange in guanacos. Moreover, no reports could 
be found regarding use of moxidectin in that ani-
mal species. In related animal species (llamas, Lama 
glama; alpacas, Vicugna pacos), other macrocyclic 
lactones had been successfully used for treatment of 
the disease (Geurden et al., 2003; Leroy et al., 2003; 
Twomey et al, 2008). 
It was decided to use moxidectin, because of its 
confirmed efficacy against the disease in cattle and 
sheep, species in the same order (Artiodactyla) as the 
guanacos. A dose rate of 0.2 mg/kg bodyweight has 
been selected on the basis of its efficacy in sheep (Fth-
enakis et al, 2000). The increased safely of the drug in 
adult mammals has also been taken into account. For 
safely considerations, however, the two animals were 
monitored at regular intervals post-treatment. 
No adverse reactions were recorded following 
administration of the drug, confirming the safely of 
the product. Moreover, animals were effectively cured, 
as confirmed by failure to recover mites (21 d post-
treatment) and subsidence of the clinical signs (42 d 
post-treatment). 
Albeit veterinary advice, the animal owner did not 
disinfect the wooden fences surrounding the paddock, 
where the animals lived. Sarcoptic animals use fences 
for scratching, at which point, mites are transferred 
thereon and subsequently can infest other animals 
nearing on the same fences. In treatment protocols of 
sarcoptic mange in sheep, such disinfection is required 
for the effective cure of the disease (Papadopoulos and 
Fthenakis, 1999; Plant and Lewis, 2011). Nevertheless, 
the guanacos were not re-infested and were fully cured. 
As mites can survive in woods for up to 21 days (Wall 
and Shearer, 2001), one can propose that the persistent 
efficacy of moxidectin (equivalent to at least 21 days) 
protected the animals from potential re-infestation. As a 
comparison, it is mentioned that in sheep the persistent 
efficacy of moxidectin against Sarcoptes scabiei has 
been found to be between 25 to 32 days (Papadopoulos 
et al, 2000). 
All the above findings support the use of moxidec-
tin for treatment of sarcoptic mange in guanacos. 
Transmission of sarcoptic mange from guanacos to 
other animal species 
The wooden fence between the guanacos and the 
sheep and goats could have been the likely source of 
infestation for the latter two animal species. Likely, 
infestation took place as sheep and goats approached 
that fence. The disease spread quickly among these 
animals, especially as the farmer refused to carry out a 
timely treatment course of sheep and goats. Prevalence 
of the disease increased from 0% on Dl 1 to 33% (sheep 
and goats) on D32 to 100% (sheep) and 67%) (goats) on 
D53. Severity of the lesions also increased during that 
period. Moxidectin was used for effective treatment of 
the disease (Fthenakis et al, 2000). 
There is some controversy whether there is one or 
several species of & scabiei, as strains recovered from 
different animal species are morphologically similar 
(Arlian et al, 1984). Direct evidence has been provided 
by the experimental work of Arlian and others (1984) 
that varieties of S. scabiei may not be host-specific. For 
example, attempts to transfer S. scabiei var. suis from 
pigs to rabbits and dogs were unsuccessful (Arlian et 
al, 1984). On the other hand, S. scabiei from goats 
was successfully transmitted from those animals to 
sheep (Ibrahim and Abu-Samra, 1987). Concurrent 
infestation of guanacos and sheep by sarcoptic mange, 
but not specific cross-infection between these animal 
species, has previously been reported in the past (Rojas 
et al, 1993). Anecdotal evidence from South America 
(Alvarado et al, 1966) suggests that sarcoptic mange 
could have been transmitted from South American 
camelids to sheep brought in there by Europeans in the 
18th century. Moreover, Menzano and others (2008) 
provided evidence of transmission of the disease from 
chamoises (Rupicapra rupicapra) to roe deers (Capre-
olus capreolus). In recent research, carried out using 
molecular markers specific to Sarcoptes mites, it was 
found that mite populations from wild animals clus-
tered into different groups; populations from ruminants 
consisted one of these groups (Raserò et al, 2010). 
In furtherance to the present findings, where sar-
coptic mange did not appear to be transmitted from 
the guanacos to the horses, the donkeys and the dogs 
in the hobby farm, it is worth mentioning that under 
the sheep/goat farming conditions prevailing in Greece 
(Gelasakis et al, 2010), where donkeys and dogs may 
co-exist with small ruminants in the same farm (Arse-
nos et al, 2010), prevalence of sarcoptic mange in 
sheep and goats is high, whilst the disease is virtually 
non-existent in the other animal species (Charalam-
bidis, 2003). 
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Concluding remarks 
Moxidectin was found to be effective for the treat­
ment of sarcoptic mange in guanacos, at a dose rate of 
0.2 mg/kg body weight. No adverse reactions were 
observed in the treated animals. The disease was trans­
mitted to sheep and goats, at close contact with the 
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